Huperzine A

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.5, Iss.1, 2004-01, pp. : 44-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on huperzine A as a treatment for Alzheimer's disease

By Little John T   Walsh Sally   Aisen Paul S  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 209-215

Informa Healthcare

Access to resources Recommend Favorite

Bivalent Ligands Derived from Huperzine A as Acetylcholinesterase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 4, 2007-02 ,pp. : 375-387

Bentham Science Publishers

Access to resources Recommend Favorite

Huperzine A, A Potential Therapeutic Agent for Treatment of Alzheimer's Disease

By  

Current Medicinal Chemistry, Vol. 7, Iss. 3, 2000-03 ,pp. : 355-374

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine

By Zhao Q.   Tang X.C.  

European Journal of Pharmacology, Vol. 455, Iss. 2, 2002-11 ,pp. : 101-107

Elsevier

Access to resources Recommend Favorite

Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats

By Wang L.M.   Han Y.F.   Tang X.C.  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 65-72

Elsevier

Access to resources Recommend Favorite